[Other] LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features.

anhdung253 Post time 3 day(s) ago | Show all posts |Read mode
Reward50points

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features.
Chang, TG., Cao, Y., Sfreddo, H.J. et al.
Nat Cancer (2024).
https://doi.org/10.1038/s43018-024-00772-7

Best Answer

Please adopt Full pdf version of Nat Cancer [*] [*] [*] . 2024 Jun 3. doi: 10.1038/s43018-024-00772-7 LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic featuresTian-Gen Chang # 1, Yingying Cao # 1, Hannah J Sfreddo # 2, Saugato Rahman Dhruba 1, Se-Hoon Lee 3, Cristina Valero 2, Seong-Keun Yoo 4 5 6, Di ...

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
drans1 Post time 3 day(s) ago | Show all posts

LORIS robustly predicts patient outcomes with immune checkpoint blockade therapy using common clinical, pathologic and genomic features

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    52086

Latest Reply

Return to the list